Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years by Cecilia Monge, Tim F. Greten

Get full text

Current frontline approaches in the management of hepatocellular carcinoma: the evolving role of immunotherapy by Gagandeep Brar, Tim F. Greten, Zachary J. Brown

Get full text

Development of shellfish allergy after exposure to dual immune checkpoint blockade by Zachary J Brown, Bernd Heinrich, Tim F Greten

Get full text

Integration of circulating tumor DNA in biliary tract cancer: the emerging landscape by Joy A Awosika, Cecilia Monge, Tim F Greten

Get full text

Evaluating the impact of hydroxychloroquine on mouse lymphocyte proliferation and cytokine production in vivo and in vitro by Simon Wabitsch, Justin D. McCallen, Chi Ma, Tim F. Greten

Get full text

Protocol for establishing liver tumors via ultrasound-guided intrahepatic injection prior partial hepatic resection in a mouse model by Shadin Ghabra, Rajiv Trehan, Francisco Rodriguez-Matos, Chi Ma, Tim F. Greten

Get full text

Liver Cancer Neuroscience: Regulating Liver Tumors via Selective Hepatic Vagotomy by Kylynda C. Bauer, Shadin Ghabra, Chi Ma, Lee Chedester, Tim F. Greten

Get full text

Tumour-Associated Transcripts and EGFR Deletion Variants in Colorectal Cancer in Primary Tumour, Metastases and Circulating Tumour Cells by Silke Lankiewicz, Eva Rother, Silke Zimmermann, Christiane Hollmann, Firouzeh Korangy, Tim F. Greten

Get full text

Safety in treatment of hepatocellular carcinoma with immune checkpoint inhibitors as compared to melanoma and non-small cell lung cancer by Zachary J. Brown, Bernd Heinrich, Seth M. Steinberg, Su Jong Yu, Tim F. Greten

Get full text

Checkpoint Inhibitors Modulate Plasticity of Innate Lymphoid Cells in Peripheral Blood of Patients With Hepatocellular Carcinoma by Bernd Heinrich, Bernd Heinrich, Benjamin Ruf, Varun Subramanyam, Yuta Myojin, Chunwei W. Lai, Chunwei W. Lai, Amanda J. Craig, Jianyang Fu, Changqing Xie, Alexander Kroemer, Tim F. Greten, Tim F. Greten, Firouzeh Korangy

Get full text

Tumor induced hepatic myeloid derived suppressor cells can cause moderate liver damage. by Tobias Eggert, José Medina-Echeverz, Tamar Kapanadze, Michael J Kruhlak, Firouzeh Korangy, Tim F Greten

Get full text

miR-130a and miR-145 reprogram Gr-1+CD11b+ myeloid cells and inhibit tumor metastasis through improved host immunity by Hiroki Ishii, Suman K. Vodnala, Bhagelu R. Achyut, Jae Young So, M. Christine Hollander, Tim F. Greten, Ashish Lal, Li Yang

Get full text

Hepatocellular Carcinoma Survival by Etiology: A SEER‐Medicare Database Analysis by Gagandeep Brar, Tim F. Greten, Barry I. Graubard, Timothy S. McNeel, Jessica L. Petrick, Katherine A. McGlynn, Sean F. Altekruse

Get full text

Hydroxychloroquine can impair tumor response to anti-PD1 in subcutaneous mouse models by Simon Wabitsch, John C. McVey, Chi Ma, Benjamin Ruf, Olena Kamenyeva, Justin D. McCallen, Laurence P. Diggs, Bernd Heinrich, Tim F. Greten

Get full text

NAFLD indirectly impairs antigen-specific CD8+ T cell immunity against liver cancer in mice by John C. McVey, Benjamin L. Green, Benjamin Ruf, Justin D. McCallen, Simon Wabitsch, Varun Subramanyam, Laurence P. Diggs, Bernd Heinrich, Tim F. Greten, Chi Ma

Get full text

585 Ofranergene obadenovec (VB-111) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single-center, single-arm phase II trial by David E Kleiner, Tim F Greten, Cecilia Monge, Seth M Steinberg, Changqing Xie, Yuta Myojin, Kelley Coffman, Bradford J Wood, Bernadette Redd, Donna M Hrones, Elliott B Levy

472 Anti-VEGF treatment amplifies immune checkpoint inhibitor induced immune responses by targeting B and regulatory T cells by Patrick Huang, Chi Ma, Tim F Greten, Firouzeh Korangy, Benjamin Ruf, William Telford, Mohamed-Reda Benmebarek, Cihan Oguz, Yuta Myojin, Matthias Seifert, Justin Lack, Kylynda Bauer, Marina Villamor Paya

Anti–PD-1 in Combination With Trametinib Suppresses Tumor Growth and Improves Survival of Intrahepatic Cholangiocarcinoma in MiceSummary by Simon Wabitsch, Mayank Tandon, Benjamin Ruf, Qianfei Zhang, Justin D. McCallen, John C. McVey, Chi Ma, Benjamin L. Green, Laurence P. Diggs, Bernd Heinrich, Tim F. Greten

Get full text

VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial by Tim F Greten, Cecilia Monge, Seth M Steinberg, William Douglas Figg, David Kleiner, Changqing Xie, Yuta Myojin, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, Bernadette Redd, Kelley Coffman-D'Annibale

Get full text

Adenosine A2a receptor inhibition increases the anti-tumor efficacy of anti-PD1 treatment in murine hepatobiliary cancers by Yuta Myojin, Justin D. McCallen, Chi Ma, Kylynda C. Bauer, Benjamin Ruf, Mohamed-Reda Benmebarek, Benjamin L. Green, Simon Wabitsch, John C. McVey, Claude Fu, Changqing Xie, Tim F. Greten

Get full text